Oxytocin antagonists: Clinical and scientific considerations

Experimental Physiology

Volumn 86, Issue 2, 2001, Pages 297-302

  Thornton, S ^a   Vatish, M ^a   Slater, D ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM SULFATE; NITRIC OXIDE DONOR; OXYTOCIN ANTAGONIST; OXYTOCIN RECEPTOR; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SALBUTAMOL; TERBUTALINE; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN V1 RECEPTOR;

AMNION FLUID; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; DUCTUS ARTERIOSUS; FEMALE; FETUS; HORMONE ACTION; HUMAN; LOW BIRTH WEIGHT; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; OXYTOCIN BLOOD LEVEL; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREMATURE LABOR; TOCOLYSIS; VASOPRESSIN BLOOD LEVEL;

EID: 0035065693     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/eph8602186     Document Type: Article

References (44)

1. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women
2. Beta-agonists for the care of women in preterm labour
3. The effect of early labour and maternal analgesia on fetal plasma vasopressin
4. Human myometrium contains immunoreactive arginine vasopressin before and after the onset of labour
5. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: Effects of the oxytocin antagonist atosiban
6. Receptor-mediated uterine effects of vasopressin and oxytocin in non-pregnant women
7. Release of oxytocin and vasopressin by the human foetus during labour
8. Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition
9. Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy
10. Oxytocin in maternal circulation and amniotic fluid during pregnancy
11. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: Fetal plasma concentrations and cardiorespiratory changes
12. Oxytocin receptors and human parturition: A dual role for oxytocin in the initiation of labour
13. Oxytocin receptors in the human uterus during pregnancy and parturition
14. Oxytocin secretion and human parturition: Pulse frequency and duration increase during spontaneous labor in women
15. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions
16. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human
17. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor
18. Tocolytics for preterm labor: A systematic review
19. Possible mechanisms of high blood levels of vasopressin during the neonatal period
20. Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus
21. The length of the cervix and the risk of spontaneous premature delivery
22. Arginine vasopressin in amniotic fluid, arterial and venous cord plasma and maternal venous plasma
23. Fasting and the precipitation of labor. The Yom Kippur effect
24. Indomethacin tocolysis in preterm labour
25. Expression of oxytocin receptor in human pregnant myometrium
26. Betamimetics in preterm labour: An overview of the randomized controlled trials
27. Glyceryl trinitrate and ritodrine in tocolysis: An international multicenter randomized study
28. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor
29. Immunoreactive oxytocin and vasopressin in the non-pregnant human uterus and oviductal isthmus
30. 1 vasopressin receptors as well as oxytocin receptors
31. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth
32. Is tocolytic magnesium sulphate associated with increased total paediatric mortality?
33. Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation
34. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study
35. Neonatal complications after the administration of indomethacin for preterm labor
36. Amniotic oxytocin and vasopressin in relation to human fetal development and labour
37. Neonatal effects of nifedipine and ritodrine for preterm labor
38. Nifedipine and ritodrine in the management of preterm labor: A randomized multicenter trial
39. Vasopressin concentration in cord blood: Correlation with method of delivery and cord pH
40. The effect of labour and maternal oxytocin infusion on fetal plasma concentration
41. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue
42. Plasma oxytocin during the first and second stages of spontaneous human labour
43. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban
44. Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labour